-
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Analysts
Source: Buzz FX / 07 Feb 2025 06:07:10 America/New_York
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Analysts Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Aclaris Therapeutics, Inc. ( NASDAQ:ACRS - Get Free Report ) has been assigned an aver
Read more...